A Phase 1, Open-Label, Dose-Escalation Study of Selinexor Plus Ruxolitinib in Patients with Treatment-Naïve Myelofibrosis by Ali, Haris, Kishtagari, Ashwin, Maher, Keri, Mohan, Sanjay R, Ansaldo, Karen, Wang, Xulong, Chamoun, Kamal, Prchal, Josef T., Tantravahi, Srinivas K.

Get full text

Abstract PR-002: A phase II pilot trial of nivolumab (N) + albumin bound paclitaxel (AP) + paricalcitol (P) + cisplatin (C) + gemcitabine (G) (NAPPCG) in patients with previously u... by Borazanci, Erkut, Jameson, Gayle S., Sharma, Sunil, Tsai, Frank, Korn, Ronald L., Caldwell, Lana, Ansaldo, Karen, Ting, David T., Roe, Denise, Bermudez, Anna, Von Hoff, Daniel D.

Get full text

Abstract PO-015: A phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with previously untreated m... by Jameson, Gayle S., Borazanci, Erkut H., Von Hoff, Daniel D., Rabinowitz, Joshua D., Gordon, Michael S., LeGrand, Sarah D., Snyder, Courtney, Ansaldo, Karen, Roe, Denise J., Han, Haiyong

Get full text

A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelof... by Mascarenhas, John O., Rampal, Raajit, El Chaer, Firas, Gupta, Vikas, Shimoda, Kazuya, Kiladjian, Jean-Jacques, Passamonti, Francesco, Bose, Prithviraj, Scandura, Joseph M., Mesa, Ruben, Rein, Lindsay A.M., Yuda, Junichiro, Ross, David M, Devos, Timothy, Talpaz, Moshe, Hoffman, Ronald, Kabir, Sujan, Li, Zhonggai, Foulks, Jason M., Ansaldo, Karen, Seki, Masataka, Peddagali, Vishnu, Shah, Jatin, Harrison, Claire

Get full text

Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, Showed Durable Clinical Response and Sustained Hematological Improvement in Relapsed/Refractory Myelofibro... by El Chaer, Firas, Rein, Lindsay A.M., Yuda, Junichiro, Shimoda, Kazuya, Takami, Akiyoshi, Ichii, Michiko, McCloskey, James, Scandura, Joseph M., Iurlo, Alessandra, Bose, Prithviraj, Haque, Tamanna, Lucchesi, Alessandro, Shirane, Shuichi, Benevolo, Giulia, Amanam, Idoroenyi, Kiladjian, Jean-Jacques, Vachhani, Pankit, Tantravahi, Srinivas K, Onishi, Yasushi, Rinaldi, Ciro, Rotta, Marcello, Granacher, Nikki, Patel, Anand Ashwin, Loschi, Michael, Alimam, Samah, Bradley, Terrence, Cheung, Stanley, Ribrag, Vincent, Kabir, Sujan, Ansaldo, Karen, Seki, Masataka, Loksa, Vincent, Li, Zhonggai, Foulks, Jason M., Shah, Jatin, Rampal, Raajit

Get full text

Abstract CT163: A Phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreatic c... by Jameson, Gayle S., Borazanci, Erkut H., Rabinowitz, Joshua D., Propper, David, Ansaldo, Karen, Roe, Denise J., Hoff, Daniel D. Von

Get full text

Abstract B27: A phase Ib/II trial of high-dose (HD) ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreati... by Jameson, Gayle S., Borazanci, Erkut H., Rabinowitz, Joshua, Ansaldo, Karen, LeGrand, Sarah, Propper, David, Snyder, Courtney, Gordon, Michael, Roe, Denise, Hoff, Daniel D. Von

Get full text

Abstract CT152: A Phase II pilot trial of nivolumab (N) + albumin bound paclitaxel (AP) + paricalcitol (P) + cisplatin (C) + gemcitabine (G) (NAPPCG) in patients with previously un... by Borazanci, Erkut H., Jameson, Gayle, Korn, Ronald Lee, Caldwell, Lana, Ansaldo, Karen, Hendrickson, Kristin, Marceau, Katie, Gosselin, Kevin, Hoff, Daniel D. Von

Get full text

Abstract CT261: A Phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naïve myelofibrosis by Ali, Haris, Kishtagari, Ashwin, Maher, Keri, Mohan, Sanjay, Ansaldo, Karen, Wang, Xulong, Chamoun, Kamal, Prchal, Josef T., Tantravahi, Srinivas K.

Get full text

Abstract LB-003: High complete and partial response rate in a phase Ib pilot trial with cisplatin plus albumin-bound paclitaxel and gemcitabine in patients with advanced pancreatic... by Jameson, Gayle S., Borazanci, Erkut, Poplin, Elizabeth, Barrett, Michael T., Crowley, John, Rosenthal, Adam, Stoll-D'Astice, Amy, Ansaldo, Karen L., Boone, Steven, Lebron, Leticia, Ramanathan, Ramesh K., Korn, Ronald L., Von Hoff, Daniel D.

Get full text

Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials by Borad, Mitesh J., Soman, Arundhati D., Benjamin, Martin, Casa, Daniel, Tembe, Waibhav D., Piper, Barbara F., Ramanathan, Ramesh, Tibes, Raoul, Jameson, Gayle, Ansaldo, Karen, Von Hoff, Daniel D.

Get full text

Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study by Neldam, Steen, Edwards, Colin, Jones, Russell

Get full text